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Abstract
Infections with Leishmania parasites of the Leishmania Viannia subgenus give rise to both localized cutaneous (CL), and
metastatic leishmaniasis. Metastasizing disease forms including disseminated (DCL) and mutocutaneous (MCL) leishmaniasis
result from parasitic dissemination and lesion formation at sites distal to infection and have increased inflammatory
responses. The presence of Leishmania RNA virus (LRV) in L. guyanensis parasites contributes to the exacerbation of disease
and impacts inflammatory responses via activation of TLR3 by the viral dsRNA. In this study we investigated other innate
immune response adaptor protein modulators and demonstrated that both MyD88 and TLR9 played a crucial role in the
development of Th1-dependent healing responses against L. guyanensis parasites regardless of their LRV status. The
absence of MyD88- or TLR9-dependent signaling pathways resulted in increased Th2 associated cytokines (IL-4 and IL-13),
which was correlated with low transcript levels of IL-12p40. The reliance of IL-12 was further confirmed in IL12AB2/2 mice,
which were completely susceptible to infection. Protection to L. guyanensis infection driven by MyD88- and TLR9-dependent
immune responses arises independently to those induced due to high LRV burden within the parasites.
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Introduction
In Latin America, infections with protozoan, obligate intracel-
lular parasites of the Leishmania Viannia subgenus, such as L.
braziliensis, L. panamensis and L. guyanensis give rise to cutaneous
(CL), and metastasizing leishmaniasis, which includes disseminated
(DCL) and mucocutaneous (MCL) leishmaniasis. Infections occur
following transmission to humans via the bite of infected sand flies
[1]. MCL is characterized by parasitic dissemination that
promotes destructive secondary skin lesions. This metastasis may
have tissue-specificity, spreading to the mucosa of mouth and nose
in 5 to 10% of individuals with resolved CL [1,2]. MCL pathology
is associated with chronic hyper-inflammation, concomitant with a
modulation of T helper cytokines and cytotoxic T cell activity [3–
7]. Studies have shown that host genetic polymorphisms (such as a
single base pair substitution in the IL-6 and TNF-a promoters) [8–
10], immune-status, and parasite derived virulence factors [11] are
associated with the development of clinical MCL.
Previously, we reported that elevated pro-inflammatory im-
mune response generation in L. guyanensis infected macrophages
relies on the recognition of high levels of an endosymbiotic dsRNA
virus of the Totiviridae family within metastasizing L. guyanensis
promastigotes (derived from either the hamster model or human
MCL isolates). The viral dsRNA genome of the Leishmania RNA
virus (LRV) is recognized by the TRIF-dependent TLR3 signaling
pathway, which resulted in an increased secretion of inflammatory
cytokines and chemokines and exacerbated susceptibility to
infection [3]. Although the absence of TLR7 in macrophages
decreased LRV-induced pro-inflammatory mediators in vitro, it
showed no role in progression of leishmanial disease in our mouse
model [3].
In CL, a T-helper 1 (Th1) response is associated with
protection, and given by high IFN-c production and efficient
intracellular parasite killing by nitric oxide. Conversely, a Th2
response is associated with susceptibility to infection which is
driven by high IL-4, and IL-13 and reduced intracellular parasite
killing due to increased Arginase-1 activity [12]. Furthermore,
immunosuppressive IL-10 also impairs Leishmania parasite disease
resolution and promotes lesion persistence and high parasite
burden [12]. Previous work has clearly demonstrated that, for both
L. major and L. (Viannia) braziliensis, the absence of MyD88-
dependent signaling pathways modulated the Th1/Th2 balance
following in vivo footpad infection and resulted in increased
susceptibility to infection [13–18]. Further studies described that
the impaired ability of MyD88-deficient (MyD882/2) mice to
develop Th1-dependent immune responses was due to reduced IL-
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12 production [17]. This consequently elevated production of the
Th2 cytokine, IL-4 and IL-13, may explain why these mice
displayed reduced dendritic cell maturation and naı¨ve T cells
priming following infection [14,15,19]. Furthermore, a role for
TLR9 was also implicated in these responses as both models
displayed a transient increase in susceptibility, evidenced by an
increased peak in footpad swelling, associated with elevated
parasite levels [18,20,21].
The TLR9 signaling pathway is triggered after the recognition
of foreign unmethylated CpG DNA. Its position on the internal
aspect of the macrophage phagosomal compartment and plasmo-
cytoid dendritic cells makes it especially sensitive to intracellular
pathogens, such as is Leishmania. All Toll-like receptors rely on the
MyD88 adaptor protein for signal transduction (except TLR3,
which is uniquely TRIF-dependent) and may thus explain the
common susceptible phenotype of MyD882/2 and TLR92/2
mice for L. major and L. braziliensis infection.
Given the potential application for TLR-ligands such as CpG
motifs to act as adjuvants in vaccination strategies [22,23] this
study assesses if resistance to L. guyanensis parasite infection is
mediated by MyD88, and TLR9 [22,23]. More importantly our
study evaluates if host recognition of LRV1 could impair these
protective immune responses, which will provide much needed
information into the applicability for TLR-ligand based adjuvants
being used in vaccination strategies against leishmaniasis in Latin
America.
Materials and Methods
Ethical Statement
All the mice experiments were approved by the Ethics and
Veterinary office regulations of the state of Vaud (SAV),
Switzerland. Our laboratory has the administrative authorization
numbers 2113-1 and 2113-2.
Animals
8 to 10 weeks old C57BL/6 mice were purchased from Harlan
Laboratories (Netherlands). MyD882/2 [24] and TLR92/2 mice
[25] were obtained Prof. S. Akira (Osaka University, Japan) via P.
Launois (WHO-IRTC, Lausanne, Switzerland). IL12AB2/2 mice
[26] were obtained from G. Alber (University of Leipzig,
Germany). Mice were maintained under pathogen-free conditions
at the animal facility of the Center of Immunity and Immunology,
Lausanne (Switzerland). All mutant and deficient mice were
crossed onto a C57BL/6 background for at least eight generations.
Each experiment contained at least 4 mice per group.
Parasite and Cell Culture
The L.g. LRVhigh (M5313) and L.g. LRVlow (Lg17) L. guyanensis
parasites used in this study were derived from the strain L.
guyanensis (L.g. M5313(M+),WHI/BR/78/M5313) from CIDEIM
(Centro Internacional de Entrenamiento e Investigaciones Me´d-
icas) [27] and LRV burden was previously determined [3].
Parasites were cultured at 23uC in M199 medium (Gibco)
consisting of 10% FBS, 1% penicillin/streptomycin, and 5%
Hepes (Sigma-Aldrich), or grown in freshly prepared Schneider’s
Insect Medium (Sigma-Aldrich) supplemented with 10% heat-
inactivated fetal bovine serum, 2 mM L-glutamine, 1% penicillin/
streptomycin (Gibco).
Mouse Infection and Parasite Quantification
36106 parasites of L.g. LRVlow (Lg17), and L.g. LRVhigh
(M5313) were infected into the hind footpads of mice. Weekly
footpad swelling measurements were taken using a Vernier caliper.
Parasite burden was quantified within the L. guyanensis infected
footpads using the standard curve real time PCR quantification
method based on Leishmania Kmp11 specific primers: 59-
GCCTGGATGAGGAGTTCAACA-39 and 59-
GTGCTCCTTCATCTCGGG-39on cDNA reverse-transcribed
from total RNA extracted from footpad lysates. Briefly, footpads
were homogenized using the Tissuelyzer (Qiagen), and total RNA
was extracted using TRIzol reagent (Invitrogen). cDNA was
synthesized using SuperScript II Reverse Transcriptase (Invitro-
gen), followed by purification using the QIAquick PCR purifica-
tion Kit (Qiagen). Gene expression levels were analyzed using the
LightCycler480 system (Roche Applied Science). Absolute parasite
burden was determined using a standard curve for Leishmania
Kmp11 gene content with a pre-determined number of L.
guyanensis parasites.
In vitro Restimulation of Lymph Node Cells and Cytokine
Quantification
Draining popliteal lymph nodes were extracted from mice and
stimulated in complete DMEM (Gibco) with a final concentration
of 10% heat-inactivated FBS, 1% penicillin/streptomycin, 2 mM
L-glutamine, 561025 M of b-mercaptoethanol and 1% HEPES
(Sigma-Aldrich) at 56106/ml cells with 16106/ml UV-irradiated
L. guyanensis promastigotes. After 72 hours, levels of IFN-c, IL-4,
IL-10, and IL-13 (eBioscience) and IL12p70 (BD Biosciences) were
quantified by ELISA in cell-free culture supernatants. In each case
the manufacturer’s protocols were explicitly followed.
Quantification of Cytokine Transcripts in the Draining
Lymph Nodes of Infected Mice
RNA was extracted from draining popliteal lymph node cell
suspensions using TRIZol reagent (Life technologies) and then
clean and concentrated using appropriate columns from Zymor-
esearch. cDNA was reverse-transcribed and purified as described
previously [3]. Relative quantification at the transcript level was
performed by qRT-PCR using the Lightcycler480 system (Roche
applied sciences) and results were calculated using the 22DDCT
method with Tata binding protein (Tbp) as a reference gene and
normalized to give the average expression level of the WT
C57BL/6 a value of 1. Gene specific primers used were the
following: Tbp-59-CCGTGAATCTTGGCTGTAAAC-39, 39-
TCCAGAACTGAAAATCAACGC-59; Il4-59-CGGAGATG-
GATGTGCCAAAC-39, 39-AGCCCTACAGACGAGCT-
CACTC-59; Il12p40-59-GGAAGCACGGCAGCAGAATAA-39,
39-CTTGAGGGAGAAGTAGGAATG-59; Il12p35-59-AG-
GACTTGAAGATGTACCAG-39, 39-CATTCTGTGTGAG-
GAGGG-59; Il13-59-GAGGAGCTGAGCAACATC-39, 39-
GTCAGGGAATCCAGGGCTA-59; Il10-59-AC-
CTGCTCCACTGCCTTGCT-39, 39-GGTTGCCAAGCCT-
TATCGGA-59; IFN-c-59- GGATGCATTCATGAGTATTG-
39, 39-GGAGTCCTTCGCCTTTTC-59.
Results
MyD88 and TLR9 are Involved in the Development of
Resistance to L. guyanensis Infection in Mice, Irrespective
of LRV Presence
The ability of TLR9 and MyD88 to impact immune responses
against L.g. LRVhigh and L.g. LRVlow parasites was investigated
using subcutaneous footpad infection in a murine model. These
two isolates were derived from the M5313 strain of L. guyanensis
based on reproducible disseminated lesion development in the
Golden hamster model of infection [27]. The ability of these
TLR9 and MyD88 in Protection against L. guyanensis
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isolates to induce secondary lesion development could be reliant
on their high LRV viral burden [3].
Following infection, we could ascertain that L. guyanensis isolates,
regardless of their LRV burden, displayed similar disease evolution
phenotypes in MyD882/2 and TLR92/2 mice. More specifically,
we observed that L. guyanensis infection in MyD882/2 mice
induced non-healing, progressive lesions that were associated with
increased parasite load (Fig. 1). However, only the MyD882/2
infected with the L.g. LRVhigh developed sever ulcers at the
footpad injection site (Fig. 1A). This increase in susceptibility was
correlated to an increased parasite burden in the footpad (Fig. 1C–
D). On the another hand, the TLR92/2 mice displayed a
transient increased peak in footpad swelling (Fig. 1A–B) that
correlated with a transient increased in parasitemia at 4 weeks post
infection (Fig. 1), and this after being infected either with L.g.
LRVlow or L.g. LRVhigh parasites. Interestingly, the L.g. LRVhigh
infected TLR92/2 mice with resolved lesions retained a higher
degree of parasitemia as compared to wild-type C57BL/6 mice at
week 10 (Fig. 1C).
Additionally, we also analyzed the role of other MyD88-
dependent TLRs and from our results we could exclude a likely
role for TLR2, and TLR4 signaling pathway in resistance to L.
guyanensis as these mice display similar footpad swelling profiles as
wild-type mice following infection with either L.g. LRVhigh or L.g.
LRVlow parasites (Fig. S1).
Increased Susceptibility of MyD882/2 and TLR92/2 Mice
to L. guyanensis Infection is Associated with the
Development of a Th2 Response
Given the clear increase in susceptibility of both the MyD882/2
and the TLR92/2 mice infected with both strains of L. guyanensis
parasites, the immune response within the draining lymph nodes
(LN) of the mice was investigated. Analysis of cytokine production
in supernatants of L.g. LRVhigh stimulated LN cells revealed that
MyD882/2 or TLR92/2 mice mounted a typical Th2 cell
response with high levels of IL-4, IL-13 associated with a decrease
in IFN-c production comparison with control mice (at week 4 and
10) (Fig. 2A). L.g. LRVlowinfection in MyD882/2 and TLR92/2
mice, also induced Th2 immune responses as shown by high IL-13
and IL-4 production nevertheless this response was less pro-
nounced than that of the same mice infected with L.g. LRVhigh
(Fig. 2B). Interestingly, TLR92/2 mice infected with L.g. LRVlow
produced significantly more IFN-c at week 10 and this could be to
counteract the earlier Th2 initiated response (Fig. 2B). Similar
results were obtained by quantitative real time PCR (qRT-PCR)
Figure 1. MyD882/2 and TLR92/2 mice are more susceptible to infection with L. guyanensis. Wild type C57BL/6, MyD882/2 and TLR92/2
mice (n$4) were infected into the hind footpads. Footpad swelling of mice infected with either L.g. LRVhigh (A) or L.g. LRVlow (B) was measured weekly
over 10 weeks using a Vernier caliper. Parasite burden in footpads of L.g. LRVhigh (C) or L.g. LRVlow (D) infected mice was determined at indicated time
points by quantitative-real time PCR using parasite-specific KMP11 primers. Results are expressed as the mean6 SEM. Significance determined at *p#
0.05, **p#0.01, ***p#0.005.
doi:10.1371/journal.pone.0096766.g001
TLR9 and MyD88 in Protection against L. guyanensis
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analysis on the draining lymph node (dLN) cells for Th1 and Th2
associated cytokines on all experimental mice groups (Fig. S2).
This clearly demonstrates that MyD88 and TLR9 deficient mice
have impaired immune response generation after infection with
L.guyanensis, regardless of the presence of LRV virions.
The Increased Susceptibility of Mice Infected with L.
guyanensis Parasites is due to the Impaired Production IL-
12
Given that previous reports have demonstrated that MyD882/2
mice following infection with different Leishmania species have an
impaired ability to produce IL-12, we tested whether this could
also be the case in LRV harboring L. guyanensis infected mice.
Firstly, we analyzed the transcript levels of IL-12p40 and IL-12p35
in the draining LN of L.g. LRVhigh or L.g. LRVlow infected
MyD882/2 and TLR92/2 mice as compared to controls. We
observed that both the MyD882/2 and the TLR92/2 mice
infected with L.g. LRVhigh parasites had significantly diminished
transcripts of IL-12p40 and IL-12p35 except for the latter in
MyD882/2 mice at 10 weeks post infection (Fig. 3A). In L.g.
LRVlow infected mice, there was no consistent modulation of IL-
12p35 as compared to WT mice at both time points analyzed
(Fig. 3A), whilst IL-12p40 transcripts were diminished in
MyD882/2 and TLR92/2mice only at 4 weeks post infection
(Fig. 3A). As modulation at the RNA level does not necessarily
reflect those at the protein level, we attempted to quantify the
amount of IL-12p40 protein in the culture supernatant by ELISA
but the levels were below the detection limit (data not shown).
Finally, the essential role of IL-12 in the development of
resistance to infection was tested by analyzing the disease evolution
profile and development of a Th1 immune response in IL-12AB2/
2 mice (that do not express functional IL-12) in infections with L.g.
LRVhigh parasites. As with infections with other Leishmania strains,
IL12AB2/2 mice were completely susceptible to infection,
resulting in progressive, ulcerating lesion development and
increased parasite burden (Fig. 3B and 3C). This necessitated
the sacrifice of these mice at week 8 and confirmed that IL-12 was
sufficient for the development of resistance to infection in C57BL/
6 mice infected with L. guyanensis parasites, even when carrying a
high burden of LRV.
Discussion
The purpose of this study was to elucidate the role of MyD88
and TLR9 in disease progression and immune response genera-
tion in mice infected with L. guyanensis, and to determine if a high
Leishmania RNA virus (LRV) burden within promastigotes could
impair these protective immune responses.
Our experimental data clearly supported a role for the innate
immune system and MyD88-dependent signaling pathways in the
development of resistance to infection with L. guyanensis, and also
implied a partial role for the MyD88 dependent, TLR9 signaling
pathway. The results show that protective immune responses
elicited via MyD88 and TLR9 arise independently to those
mediated by TLR3 and viral dsRNA recognition. As evidenced by
the fact that infection with either L.g LRVhigh or L.g LRVlow
parasites into the MyD882/2 or TLR92/2 mice were more
susceptible than wild type controls regardless of the viral burden.
However, presence of a high LRV burden does influence overall
disease severity, where all mice infected with L.g. LRVhigh showed
an increased footpad swelling peak as compared to L.g. LRVlow.
This increase in susceptibility is reliant on TLR3 recognition of
viral dsRNA that seems to modulate Th1/Th2 immune response
polarization or to impaired parasite killing mechanisms.
As with other studies, we observed that the susceptible disease
phenotype was more severe in MyD882/2 mice than in TLR92/
2, and implies that other TLRs (that utilize MyD88) could
participate in the disease resolution and elimination of parasites.
Currently, we can exclude a role for TLR7 and the cell membrane
localized TLR4 and TLR2, as mice deficient for these receptors
Figure 2. Absence of MyD88 and TLR9 signaling pathways results in a more Th2-polarized immune response. At specific time points,
draining lymph node cells were restimulated with UV-irradiated L. guyanensis parasites with L.g. LRVhigh (A) or L.g. LRVlow (B) for 72 hours and cytokine
levels were quantified by ELISA. Results are expressed as mean 6 SEM. Significance determined at *p#0.05, **p#0.01, ***p#0.005.
doi:10.1371/journal.pone.0096766.g002
TLR9 and MyD88 in Protection against L. guyanensis
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do not display any discernable difference in disease phenotype in
either the L.g LRVhigh or L.g LRVlow infected mice [3].
In this study, we specifically demonstrated that the loss of
MyD88 and TLR9 signaling pathways resulted in a modulation of
the Th1/Th2 balance, with a significant increase in Th2
associated cytokines (IL-4 and IL-13) in the draining lymph nodes
of both MyD882/2 and TLR92/2 mice. This Th2-polarized
immune response could also be correlated with a diminished
production of IL-12p40 and IL-12p35 transcripts ex vivo, following
infection, which we also confirmed was essential for healing and
elimination of parasites. Although other studies have demonstrated
a role for both MyD88 and TLR9 in the generation of IL-12 and
IFN-c-dependent protective immune responses murine models of
infection with other Leishmania parasites (specifically L. major, L.
donovani and L.(V) braziliensis [13–15,17,19–21]) this study demon-
strates that the viral immune response driven by LRV does not
impair protection conferred by MyD88 and TLR9 pathways nor
those elicited due to IL-12.
Although there is currently no vaccine available against
leishmaniasis, the past has shown us that protection is, indeed,
possible. Leishmanization - the injection of live parasites into an
individual to induce protection- was a common practice in the
Middle East but adverse events such as uncontrolled skin lesions,
HIV-co-infections, and variability in protection limited it potential
application on a large scale. Thus, several different vaccine
strategies have been investigated in the pursuit of the anti-
Leishmania vaccine, including whole organism formulations using
live-attenuated or killed organisms, and defined vaccines targeting
Leishmania specific motifs such as the LACK antigen or DNA-
based vaccines. Unfortunately, however, poor immunogenicity
and other factors have limited their success.
Given this limitation, CpG based motifs (that are recognized by
TLR9) and other MyD88 stimulating ligands have been investi-
gated for their potential as adjuvants to boost the development of
protective immune responses against Leishmania parasites [28,29].
Studies have shown that regardless of the vaccine antigen used
CpG-oligodeoxynucleotides (CpG-ODN) enhanced the protection
Figure 3. MyD88 and TLR9 are involved in IL-12 production following infection and their absence increases susceptibility to
infection. At indicated time points RNA from draining popliteal lymph node cells of wild-type, TLR92/2 and Myd882/2 mice infected by L.g. LRVhigh
(Fig3A left panel) or L.g. LRVlow (Fig3A right panel) were reverse-transcribed into cDNA and relative transcript levels were determined using gene
specific primers by quantitative real time PCR. Results are expressed as mean6 SEM of the individual mice analyzed per group with the average value
for the C57BL/6 mice given a value of 1. A.U refers to Arbitrary Units of fold change. (B) Mice (n$4) were infected in the hind footpads and footpad
swelling was measured weekly over 8 weeks using a Vernier caliper. (D) At 8 weeks post-infection mice were sacrificed and footpad parasite burden
was determined using parasite specific Kmp11 primers. Results are expressed as the mean 6 SEM. Significance determined at *p#0.05, **p#0.01,
***p#0.005.
doi:10.1371/journal.pone.0096766.g003
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of mice subsequently challenged with the parasites. Specifically,
vaccination of susceptible BALB/c mice with soluble Leishmania
antigen (SLA) and CpG provided enhanced protection in
challenged mice that persisted for over 6 months [30]. This
protection was linked with the development of memory CD4 and
CD8 T cell immune responses [31]. Given that TLR9 responses
remain protective regardless of the LRV burden in infecting
parasites, CpG-based adjuvants stand as a promising addition for
vaccines serving regions that are endemic to parasites of mixed
LRV-content.
It is important to note, however, that TLR-stimulation can
result in potent inflammatory responses that could exacerbate
severity of Leishmania infections, as we previously reported for the
pathogenic TLR3 stimulation by high viral dsRNA burden in L.
guyanensis [3]. Thus, further experimentation is required to gauge
the effects of all TLR-based adjuvants on infections with parasite
species to better tailor their therapeutic use in leishmaniasis.
Supporting Information
Figure S1 TLR22/2 and TLR42/2 mice display no
difference in footpad swelling following L. guyanensis
infection. Mice (n$5) were infected into the hind footpads with
either L.g. LRVhigh or L.g. LRVlow, and footpad swelling was
measured weekly over 10 weeks using a vernier caliper.
(TIF)
Figure S2 Absence of MyD88 and TLR9 signaling
pathways increases transcripts of Th2 cytokines. At
specific time points RNA from draining popliteal lymph node cells
of wild-type, TLR92/2 and MyD882/2 mice infected by L.g
LRVhigh (A) or L.g LRVlow (B) were reverse-transcribed into cDNA
and relative transcript levels were determined using gene specific
primers by quantitative real time PCR. Results were expressed as
mean6 SEM of the individual mice analyzed per group with the
average value for the C57BL/6 mice given a value of 1. Tbp was
used as a reference gene. A.U.: arbitrary units corresponding to
fold changes in expression. Significance determined at *p#0.05,
**p#0.01, ***p#0.005.
(TIF)
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